- At $1.21 billion, WELL’s market cap has grown by 70.60% while the share price surged 16.98% in the past year.
- WISP will still be managed independently after the $41 million acquisition by WLYYF adding impetus to the management's increase in customer acquisition into 2022.
- Amwell's share price has fallen 54.69% over the past year with the telehealth company yet to realize profits after the Converge offering.
- WELL Health is expected to announce its US IPO in 2022 after experiencing an increase in EBITDA and expanding its US digital assets with Circle Medical and WISP.
For further details see:
WELL Health Technologies: Expansion Boost Before U.S. IPO Release